leisure time -WSS

leisure time

author：leisure time 2025-10-02 23:47:26 - browse：417

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large trial of its gene therapy for Duchenne muscular dystrophy marked a clear medical breakthrough. “A massive win,” he told investors, that could lead to its approval for all patients with the fatal muscle-wasting disease regardless of age.

And yet the rest of the Duchenne community was more cautious in its enthusiasm. The study — the most rigorous test to date of a technology 30 years in the making — had technically failed, as so many had before it.

“It’s extremely frustrating,” said John Brandsema, a pediatric neurologist at Children’s Hospital of Philadelphia who worked on the study. “When you spend decades trying to bring therapies into the clinic for something so severe and just keep missing over and over again.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Does good food count as health care? Study aims to find out

explore

WSS

UnitedHealth’s board chair also owns a personal investment firm

UnitedHealth’s board chair also owns a personal investment firm

Astellas still sees hope in its gene therapy after four deaths

Does good food count as health care? Study aims to find out

Researchers explore possible ties between long Covid, menopause

NYU radiologists take on the challenge of expensive MRI machines

Wikipedia

leisure time

knowledge

Heart attack and stroke risk calculators need revising

Ransomware attacks on hospitals: Study outlines patient impact

Virginia high school admissions case could be legal follow

David Sabatini, ex

Alkermes shareholders re

Researchers explore possible ties between long Covid, menopause

How to save PrEP access — and even expand it

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

23andMe had bad news about my health. I wish a person had delivered it

Impact of Dobbs ruling felt at reproductive medicine meeting

Wikipedia

Lawmakers consider Medicare pay reforms for doctors

The explosion of genetic testing requires a new approach

FDA's Woodcock to retire early next year

Ransomware attacks on hospitals: Study outlines patient impact

A daunting task: navigating dual Medicare, Medicaid eligibility

Ransomware attacks on hospitals: Study outlines patient impact

hotspot

hotspot

explore

Wikipedia